POC HbA1c testing market seen reaching $1.76 billion by 2030

The point-of-care HbA1c testing market is forecast to grow from $1.02 billion in 2025 to $1.76 billion by 2030, driven by rising diabetes cases and demand for faster glucose monitoring. North America led the market in 2025, while Africa is expected to post the fastest growth.

Why it matters: - POC HbA1c testing gives clinicians and patients a faster way to track average blood glucose over two to three months. - The market’s growth reflects rising demand for diabetes monitoring in clinics, pharmacies and homes. - The trend matters because diabetes management depends on timely test results to help prevent complications.

What happened: - The Business Research Company released a report on the global POC HbA1c testing market for 2026 to 2035. - The report pegged the market at $1.02 billion in 2025 and forecast $1.14 billion in 2026. - The market is projected to reach $1.76 billion by 2030. - The report identified North America as the largest regional market in 2025. - The report said Africa is expected to grow fastest over the forecast period. - The report covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company offered a free sample of the report at Download a free sample of the market report. - The company also posted the full report at View the full market report.

The details: - The report said the market grew on the back of rising diabetes prevalence, broader use of long-term glucose monitoring and expansion of outpatient diagnostic services. - The report also cited greater awareness of early diabetes detection and the availability of compact, user-friendly devices. - For the forecast period, the report pointed to decentralized diagnostics, home care testing, digital diabetes management programs, preventive healthcare and investment in rapid diagnostic technologies. - The report highlighted growth in rapid POC HbA1c devices, portable and handheld systems, home-based monitoring, integrated diagnostic platforms, and greater focus on accuracy and standardization. - The report described HbA1c testing devices as tools that measure average glucose levels over time and support management of type I and type II diabetes. - Diabetes remains a chronic condition caused by insufficient insulin production or poor use of insulin by the body.

Between the lines: - The market outlook suggests testing is moving closer to the point of care and away from centralized lab workflows. - Rising diabetes cases in lower-income markets could create strong demand for affordable, accessible devices. - The growth forecast also signals that product performance and ease of use are becoming as important as basic test availability.

What's next: - The report expects the market to expand at an 11.4% CAGR through 2030. - The International Diabetes Federation projected that the number of adults living with diabetes will rise from about 589 million in 2024 to 853 million by 2050. - More than 80% of adults with diabetes live in low- and middle-income countries, which could keep pressure on providers to expand access to POC testing. - The Business Research Company said its 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

The bottom line: - POC HbA1c testing is moving from niche diagnostics to a broader diabetes management tool, with growth anchored by scale, speed and access.